• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同的组蛋白 H3 修饰谱与唾液腺肿瘤的侵袭特征相关。

Distinct histone H3 modification profiles correlate with aggressive characteristics of salivary gland neoplasms.

机构信息

Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, Srinakharinwirot University, 114 Sukhumvit 23 Wattana, Bangkok, 10110, Thailand.

Department of Oral Pathology, Faculty of Dentistry, Chulalongkorn University, Henri-Dunant Road, Pathumwan, Bangkok, 10330, Thailand.

出版信息

Sci Rep. 2022 Sep 5;12(1):15063. doi: 10.1038/s41598-022-19174-9.

DOI:10.1038/s41598-022-19174-9
PMID:36064736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9445049/
Abstract

Post-translational modification of histones is the crucial event that affect many tumor-specific traits. A diverse type of histone modifications had been reported in different cancers with prognostic implications. This study aimed to examine the degree of histone H3 modifications in salivary gland neoplasms and their associations with tumor pathologic characteristics and proliferative activity. The expression of H3K9Ac, H3K18Ac, H3K9Me3 and Ki-67 in 70 specimens of salivary gland neoplasms, consisting of 30 mucoepidermoid carcinoma (MEC), 20 adenoid cystic carcinoma (ACC) and 20 pleomorphic adenoma (PA), were investigated immunohistochemically. The immunohistochemical scoring of 3 histone modification types and Ki-67 labeling index were determined. Overall, MEC demonstrated elevated H3K9Ac level compared with benign PA. Increased H3K9Me3 in MEC was positively correlated with small nest invasion at tumor front, advanced pathologic grade, and elevated proliferative index. In addition, the significant upregulation of all 3 types of histone H3 modification was noted in solid subtype of ACC and associated with increased cell proliferation. This study indicates that salivary gland neoplasms differentially acquire distinct patterns of histone H3 modification, which impact prognostically relevant cancer phenotypes. The hyperacetylation and methylation of histone H3 could be underpinning the prognostically worsen solid type of ACC, and the trimethylation of H3K9 may be involved in aggressive characteristics of MEC.

摘要

组蛋白的翻译后修饰是影响许多肿瘤特异性特征的关键事件。不同类型的组蛋白修饰已在不同癌症中被报道,并具有预后意义。本研究旨在研究唾液腺癌中组蛋白 H3 修饰的程度及其与肿瘤病理特征和增殖活性的关系。用免疫组织化学方法检测了 70 例唾液腺癌标本(包括 30 例黏液表皮样癌(MEC)、20 例腺样囊性癌(ACC)和 20 例多形性腺瘤(PA))中 H3K9Ac、H3K18Ac、H3K9Me3 和 Ki-67 的表达。确定了 3 种组蛋白修饰类型和 Ki-67 标记指数的免疫组织化学评分。总的来说,MEC 与良性 PA 相比,H3K9Ac 水平升高。MEC 中 H3K9Me3 的增加与肿瘤前缘的小巢浸润、高级别病理分级和增殖指数升高呈正相关。此外,在 ACC 的实性亚型中观察到所有 3 种组蛋白 H3 修饰类型的显著上调,并与细胞增殖增加有关。本研究表明,唾液腺癌获得了不同的组蛋白 H3 修饰模式,这些模式影响与预后相关的癌症表型。组蛋白 H3 的乙酰化和甲基化增加可能是 ACC 实性亚型预后恶化的基础,H3K9 的三甲基化可能参与了 MEC 的侵袭性特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/3a9f421f3ad6/41598_2022_19174_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/6a093e4bed1f/41598_2022_19174_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/44b0b7375713/41598_2022_19174_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/10a9a3e54246/41598_2022_19174_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/e429eb86396a/41598_2022_19174_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/c2bd0fef2b75/41598_2022_19174_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/b84ff7e63687/41598_2022_19174_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/3a9f421f3ad6/41598_2022_19174_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/6a093e4bed1f/41598_2022_19174_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/44b0b7375713/41598_2022_19174_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/10a9a3e54246/41598_2022_19174_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/e429eb86396a/41598_2022_19174_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/c2bd0fef2b75/41598_2022_19174_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/b84ff7e63687/41598_2022_19174_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2570/9445049/3a9f421f3ad6/41598_2022_19174_Fig7_HTML.jpg

相似文献

1
Distinct histone H3 modification profiles correlate with aggressive characteristics of salivary gland neoplasms.不同的组蛋白 H3 修饰谱与唾液腺肿瘤的侵袭特征相关。
Sci Rep. 2022 Sep 5;12(1):15063. doi: 10.1038/s41598-022-19174-9.
2
Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.Runt 相关转录因子 3 的下调与唾液腺腺样囊性癌和黏液表皮样癌预后不良相关。
Cancer Sci. 2011 Feb;102(2):492-7. doi: 10.1111/j.1349-7006.2010.01787.x. Epub 2010 Nov 24.
3
Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67.唾液腺肿瘤:表皮生长因子(EGF)、表皮生长因子受体(EGFR)、ErbB-2、FAS及Ki-67的免疫组化研究
Anal Quant Cytol Histol. 2009 Oct;31(5):280-7.
4
Caveolin-1 overexpression in benign and malignant salivary gland tumors.小窝蛋白-1在涎腺良恶性肿瘤中的过表达
Tumour Biol. 2016 Feb;37(2):1863-9. doi: 10.1007/s13277-015-3968-z. Epub 2015 Sep 1.
5
Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors.Ki67和CD105作为唾液腺肿瘤增殖和血管生成标志物的表达情况。
Asian Pac J Cancer Prev. 2012;13(10):5155-9. doi: 10.7314/apjcp.2012.13.10.5155.
6
Clinical implication of CD166 expression in salivary gland tumor.CD166表达在涎腺肿瘤中的临床意义
Tumour Biol. 2015 Apr;36(4):2793-9. doi: 10.1007/s13277-014-2905-x. Epub 2014 Dec 4.
7
Immunohistochemical study of the expression of human chorionic gonadotropin-β in salivary gland tumors.人绒毛膜促性腺激素-β在涎腺肿瘤中表达的免疫组织化学研究
J Cancer Res Ther. 2018 Jul-Sep;14(5):952-956. doi: 10.4103/0973-1482.184523.
8
Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.Twist在涎腺多形性腺瘤、腺样囊性癌和黏液表皮样癌中的表达
Turk Patoloji Derg. 2016;32(1):15-21. doi: 10.5146/tjpath.2015.01343.
9
TGFβ signaling pathway in salivary gland tumors.TGFβ 信号通路在唾液腺肿瘤中的作用。
Arch Oral Biol. 2024 Jun;162:105943. doi: 10.1016/j.archoralbio.2024.105943. Epub 2024 Mar 7.
10
Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.涎腺小唾液腺癌中上皮膜抗原和 DOG1 的表达。
Ann Diagn Pathol. 2019 Dec;43:151408. doi: 10.1016/j.anndiagpath.2019.151408. Epub 2019 Sep 4.

引用本文的文献

1
Histone H3K9 Methylation Is Differentially Modified in Odontogenic Cyst and Tumors.组蛋白H3K9甲基化在牙源性囊肿和肿瘤中存在差异修饰。
Eur J Dent. 2025 Jul;19(3):688-696. doi: 10.1055/s-0044-1791681. Epub 2024 Nov 7.
2
The Significance of Modified Histone H3 in Epithelial Dysplasia and Oral Cancer.修饰组蛋白 H3 在口腔上皮异型增生和口腔癌中的意义。
Int Dent J. 2024 Aug;74(4):769-776. doi: 10.1016/j.identj.2024.01.011. Epub 2024 Feb 6.
3
Enhanced Transcriptional Signature and Expression of Histone-Modifying Enzymes in Salivary Gland Tumors.

本文引用的文献

1
A Contemporary Review of Molecular Therapeutic Targets for Adenoid Cystic Carcinoma.腺样囊性癌分子治疗靶点的当代综述
Cancers (Basel). 2022 Feb 16;14(4):992. doi: 10.3390/cancers14040992.
2
Clinical Significance of Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Salivary Gland Tumors.组蛋白去乙酰化酶(HDAC)-1、-2、-4和-6在涎腺肿瘤中的表达的临床意义
Diagnostics (Basel). 2021 Mar 14;11(3):517. doi: 10.3390/diagnostics11030517.
3
Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma.靶向人黏液表皮样癌中的 Notch 和 EGFR 信号通路。
唾液腺肿瘤中组蛋白修饰酶的转录特征和表达增强。
Cells. 2023 Oct 11;12(20):2437. doi: 10.3390/cells12202437.
4
Role of Histone Deacetylases in the Pathogenesis of Salivary Gland Tumors and Therapeutic Targeting Options.组蛋白去乙酰化酶在唾液腺肿瘤发病机制中的作用及治疗靶点选择。
Int J Mol Sci. 2023 Jun 12;24(12):10038. doi: 10.3390/ijms241210038.
5
The Epigenesis of Salivary Glands Carcinoma: From Field Cancerization to Carcinogenesis.唾液腺癌的表观遗传学:从场癌化到癌变
Cancers (Basel). 2023 Mar 31;15(7):2111. doi: 10.3390/cancers15072111.
6
Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers.涎腺癌预后因素的组织病理学方面
Cancers (Basel). 2023 Feb 15;15(4):1236. doi: 10.3390/cancers15041236.
Signal Transduct Target Ther. 2021 Jan 21;6(1):27. doi: 10.1038/s41392-020-00388-0.
4
Histone methyltransferase and drug resistance in cancers.组蛋白甲基转移酶与癌症的耐药性。
J Exp Clin Cancer Res. 2020 Aug 28;39(1):173. doi: 10.1186/s13046-020-01682-z.
5
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability.组蛋白去乙酰化酶(HDACs):进化、特异性、在转录复合物中的作用和药物作用。
Genes (Basel). 2020 May 15;11(5):556. doi: 10.3390/genes11050556.
6
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.靶向癌症治疗的表观遗传调节剂:机制和临床试验进展。
Signal Transduct Target Ther. 2019 Dec 17;4:62. doi: 10.1038/s41392-019-0095-0. eCollection 2019.
7
Epigenetic alterations in salivary gland tumors.唾液腺癌中的表观遗传学改变。
Oral Dis. 2020 Nov;26(8):1610-1618. doi: 10.1111/odi.13253. Epub 2020 Jan 22.
8
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.帕博利珠单抗和伏立诺他治疗复发性转移性头颈部鳞状细胞癌和唾液腺癌的 II 期临床试验。
Clin Cancer Res. 2020 Feb 15;26(4):837-845. doi: 10.1158/1078-0432.CCR-19-2214. Epub 2019 Dec 3.
9
H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3 Histone Tags Suggest Distinct Regulatory Evolution of Open and Condensed Chromatin Landmarks.H3K4me3、H3K9ac、H3K27ac、H3K27me3 和 H3K9me3 组蛋白标签提示开放和浓缩染色质地标监管演化的明显区别。
Cells. 2019 Sep 5;8(9):1034. doi: 10.3390/cells8091034.
10
The Emerging Role of H3K9me3 as a Potential Therapeutic Target in Acute Myeloid Leukemia.H3K9me3作为急性髓系白血病潜在治疗靶点的新作用
Front Oncol. 2019 Aug 2;9:705. doi: 10.3389/fonc.2019.00705. eCollection 2019.